US Bancorp’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-700
| Closed | -$1.05K | – | 4130 |
|
|
2023
Q1 | $1.05K | Hold |
700
| – | – | ﹤0.01% | 3838 |
|
|
2022
Q4 | $699 | Hold |
700
| – | – | ﹤0.01% | 3943 |
|
|
2022
Q3 | $1K | Hold |
700
| – | – | ﹤0.01% | 4017 |
|
|
2022
Q2 | $2K | Hold |
700
| – | – | ﹤0.01% | 3880 |
|
|
2022
Q1 | $2K | Sell |
700
-150
| -18% | -$429 | ﹤0.01% | 3860 |
|
|
2021
Q4 | $4K | Sell |
850
-3,656
| -81% | -$17.2K | ﹤0.01% | 3727 |
|
|
2021
Q3 | $38K | Sell |
4,506
-18,368
| -80% | -$155K | ﹤0.01% | 2778 |
|
|
2021
Q2 | $375K | Buy |
22,874
+150
| +0.7% | +$2.46K | ﹤0.01% | 1690 |
|
|
2021
Q1 | $502K | Buy |
22,724
+1,309
| +6% | +$28.9K | ﹤0.01% | 1485 |
|
|
2020
Q4 | $663K | Buy |
21,415
+20,715
| +2,959% | +$641K | ﹤0.01% | 1292 |
|
|
2020
Q3 | $14K | Hold |
700
| – | – | ﹤0.01% | 2919 |
|
|
2020
Q2 | $11K | Hold |
700
| – | – | ﹤0.01% | 3021 |
|
|
2020
Q1 | $5K | Buy |
700
+300
| +75% | +$2.14K | ﹤0.01% | 3215 |
|
|
2019
Q4 | $6K | Hold |
400
| – | – | ﹤0.01% | 3201 |
|
|
2019
Q3 | $6K | Buy |
+400
| New | +$6K | ﹤0.01% | 3217 |
|